Can-Fite BioPharma (CANF) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Can-Fite BioPharma Ltd. has announced an inducement offer for warrant holders to exercise their purchase rights of ordinary shares represented by American Depositary Shares at a price of $1.75. In return, the company is offering new warrants with an exercise price of $2.25, which are exercisable between 20 months to five years, depending on the terms. These new warrants and any underlying shares will initially be unregistered and subject to certain restrictions.
For further insights into CANF stock, check out TipRanks’ Stock Analysis page.